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of the six putative virulence genes were present in the clini-
cal isolates indicating their probable role in the pathogene-
sis of  B. pseudomallei infections. 
 Copyright © 2012 S. Karger AG, Basel 
 Burkholderia pseudomallei,  a Gram-negative bacilli, is 
an environmental saprophyte that possesses a remark-
able capacity to infect humans and animals, causes a po-
tentially serious infection known as melioidosis which is 
an important cause of sepsis in the tropics and is endem-
ic in South-East Asia and Northern Australia. This infec-
tion has the potential for prolonged latency periods with 
recrudescence into acute and fulminating fatal infections 
[Puthucheary, 2009]. The potential severity of acute mel-
ioidosis indicates that the organism possesses potent vir-
ulence factors. Yet after many decades of research, there 
is a paucity of knowledge in this area compared to other 
Gram-negative bacteria and only a limited number of vir-
ulence factors have been elucidated so far. Some of these 
studies have been concerned with the role of exoproducts, 
such as protease, lipase, phospholipase C, quorum sens-
ing, biofilm formation, type III secretion system and cap-
sular polysaccharide [Wierasinga et al., 2006].
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 Abstract 
 Burkholderia pseudomallei is the causative agent of melioido-
sis. We initiated this investigation with a virulent and an at-
tenuated strain of  B. pseudomallei . Pulsed-field gel electro-
phoresis was carried out initially for macrogenomic com-
parison of both strains of  B. pseudomallei . However, the 
pulsotypes obtained were identical and therefore we ap-
plied a subtractive hybridization technique to distinguish 
and determine the possible differences between the two 
strains. Six virulence strain-specific DNA fragments were ob-
tained and the encoding homolog proteins were identified 
as a xenobiotic-responsive element family of transcriptional 
regulator, a hypothetical protein, an unknown protein, a 
plasmid recombination enzyme, a regulatory protein and a 
putative hemolysin activator protein. A combination of at 
least three of these determinants was identified in 45 clinical 
isolates when screening was carried out with self-designed 
multiplex PCR targeting the six putative virulent determi-
nants. Our data demonstrated that different combinations 
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 The identification and characterization of virulence 
factors in  B. pseudomallei has been carried out using var-
ious high-powered techniques such as subtractive hy-
bridization (SH) which enables differentiation and mo-
lecular amplification of DNA fragments that are present 
in one bacterial genome (the tester strain) but absent in 
another (the driver strain). In addition, differences in rel-
ative abundance of transcripts are highlighted as well as 
genetic differences between species. Past published re-
ports have focused on genomic differences between the 
virulent  B. pseudomallei and a closely related non-infec-
tious (avirulent) family member  Burkholderia thailand-
ensis  [Reckseidler et al., 2001; Yu et al., 2006].
 In this study, we have used a virulent clinical isolate of 
 B. pseudomallei (v) and an attenuated strain of  B. pseudo-
mallei (av) , in a PCR-based SH technique to detect and 
characterize the presence of potential virulence determi-
nants and their encoded genes. The virulent strain of B. 
pseudomallei (v)  wa s isolated from the blood culture of a 
44-year-old male diabetic in 1994, who subsequently suc-
cumbed to the infection. This virulent strain was used to 
prepare antigen for serological tests in melioidosis-posi-
tive patients. Overtime, in 2003, the freshly prepared an-
tigen failed to give a positive reaction and the organism 
also did not agglutinate with our in-house polyvalent an-
tiserum. When this live organism was injected into 
Balb/C mice that were 6–7 weeks old, the rate of survival, 
in days, was at least two times longer compared to a viru-
lent strain ( table 1 ). Henceforth this strain is referred to 
as the attenuated  B. pseudomallei (av) strain. Phenotypi-
cally the virulent and attenuated strains of  B. pseudomal-
lei were identical by routine laboratory biochemical tests 
as well as by the API 20NE (bioMérieux, France) test.
 Forty-five clinical isolates of  B. pseudomallei were ob-
tained from our culture collection. These had been iso-
lated from patients in hospitals throughout Malaysia, 
from 1990 to 2008 and stored in glycerol at –80  °  C. Twen-
ty-four were from blood cultures and 21 were non-blood 
isolates. The age of the patients ranged from 8 to 68 years; 
31 were males and 14 were females. Animal ethics (Permit 
No. MIC/01/08/02/SDP(R)) and human Ethics approval 
(Permit No. 260.1) for this study had been obtained from 
the University of Malaya and the University of Malaya 
Medical Center (UMMC) review board, respectively.
 The bacterial strains were grown in Luria-Bertani 
broth and genomic DNA was extracted using i-genomic 
CTB DNA extraction mini kit (iNtRON Biotechnology). 
Two milliliters of cultured bacterial cells were centri-
fuged and lysed for 30 min in lysis buffer at 65  °  C. After 
addition of binding buffer and 80% (v/v) ethanol, the 
mixture was transferred to a column and spun. The flow-
through was discarded and the spin column was washed 
with buffer. The genomic DNA was then eluted out of the 
spin column with elution buffer.
 Pulsed-field gel electrophoresis (PFGE) was carried 
out according to previously published protocols [Chua et 
al., 2010; Chua et al., 2011; See et al., 2009]. Briefly,  B. 
pseudomallei genomic DNA was used to prepare 1.6% 
(w/v) agarose plugs [Chua et al., 2009]. These plugs con-
taining genomic DNA were digested overnight with  Spe I 
enzyme (New England BioLabs, USA) for brief profiling 
comparison study. The DNA fragments were separated 
by electrophoresis (CHEF DR II; Bio-Rad Laboratories) at 
14  °  C for 28 h at 200 V with pulse times ramped linearly 
from 5 to 65 s and the DNA fingerprints recorded.
 SH was carried out between the virulent ( v ) (tester) and 
the attenuated  (av) (driver) strains of  B. pseudomallei in 
order to isolate DNA sequences encoding for possible vir-
ulence determinants unique to  B. pseudomallei (v) strain 
as described previously [DeShazer, 2004]. The protocol of 
the A PCR-Select TM Bacterial Genome Subtraction Kit 
(Clontech, USA) was followed and the tester-specific  (v) 
DNA fragments were ligated into a pGEM  -T Vector Sys-
tem containing T7 and SP6 sequencing priming sites 
(Promega). The ligated products were then transformed 
into One Shot  TOP10 competent cells (Invitrogen, 
USA). The transformation culture was spread on LB/am-
picillin/IPTG/X-Gal plates and the white colonies carry-
ing the putative plasmids with the tester-specific  (v) DNA 
fragments were selected to undergo plasmid extraction 
using PureLink TM Quick Plasmid Miniprep Kit (Invitro-
gen, USA). The extracted plasmids were sequenced with 
T7 and SP6 primers to obtain information of genes pres-
Table 1. M ean of days of survival of mice challenged with B. pseu-
domallei
Balb/C Bacterial
strain
S urvival rate, days
chal lenge dose, CFU/ml p value
10 102 103
Male virulent (v) 27 21 10 6.9 !10–8
avirulent (av) 68 68 68
Female virulent (v) 32 23 12 3 ! 10–7
avirulent (av) 69 67 69
Mea n number of survival days calculated from each group of 
3 mice and statistical significance determined by Student’s t test.
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ent in the tester  (v) but absent in the driver  (av) strain. 
Protein homology analysis of the acquired sequences was 
performed using the BlastX program at NCBI in search 
of  Burkholderia  proteins identity determination and data 
mining through PATRIC database [Gillespie et al., 2011].
 Following the sequencing of the six fragments, six 
pairs of specific primers targeting and corresponding to 
the six potential virulence determinants were designed. 
These primer sequences are listed in  table 2 . Two sets of 
multiplex PCRs were developed to enable rapid screening 
of the 45 clinical isolates of  B. pseudomallei for the pres-
ence of any of the six virulence determinants. The first 
set consisted sequences corresponding to fragments F2, 
F3 and F4 and the second set to F1, F5 and F6. Further 
checking of primer specificity was carried out using in 
silico PCR as previously described [Teh et al., 2010; Thong 
et al., 2011]. Two separate multiplex PCRs were carried 
out on the  B. pseudomallei (v) clinical strain, attenuated 
 B. pseudomallei (av) and the 45 clinical isolates of  B. pseu-
domallei. PCR was performed in a final volume of 15   l 
containing 100 ng of DNA template, 1 ! of buffer, 0.5   M 
of each forward and reverse primers, 200   M of dNTP 
mix, 1.5 m M of MgCl 2 , 1 U of  Taq DNA polymerase (Fer-
mentas, USA) and an appropriate volume of distilled wa-
ter. Cycling parameters consisted of denaturation at 94  °  C 
for 5 min, followed by 30 cycles at 94  °  C for 30 s, 59  °  C for 
30 s, 72  °  C for 60 s and a final extension at 72  °  C for 5 min. 
The PCR products were then electrophoresed on a 1.0% 
(w/v) agarose gel and stained with ethidium bromide.
 PFGE analysis carried out on both the  (v) and the  (av) 
strains of  B. pseudomallei  resulted in similar pulsotypes 
( fig. 1 ), indicating that these two strains were indistin-
guishable in terms of macrogenomic features. Hence, SH 
was carried out between the virulent  (v) (tester) and the 
Table 2. P rimer sequences of the six putative virulence determinants
No. Sequence (5 to 3) Amplicon, bp Target
1 GCTGGAATTCGTGGAATG 466 fragment 1
CAAAGCCGATAGAATGGGAA
2 ACTTCGACCATCAGACCG 440 fragment 2
GTTGCGAATGCGATGAC
3 ACTTTCGAATGCCTTCAAC 364 fragment 3
GCTCGACTGACTCTTCATTC
4 TTACGCAAGCCAAGTCAATG
AAGCACCTTTCCCTGGAACT
219 fragment 4
5 GGTCAGACGTGAAATAATCG
GCCTGTTTGGAATAATGC
293 fragment 5
6 AAGGGAGGCAATCGACAGTA
AATCCAGACCCATTCCG
114 fragment 6
Table 3. B lastX results for strain-specific DNA fragments present in B. pseudomallei (v)
DNA fragment Size, bp Iden-
tity, %
Protein information
1 900 97 transcriptional regulator, XRE family protein (B. pseudomallei B7210)
2 520 97 hypothetical protein (B. pseudomallei 1710a)
3 490 99 unknown protein (B. pseudomallei 1026b)
4 440 95 plasmid recombination enzyme (B. multivorans CGD1)
5 400 100 regulatory protein (B. pseudomallei 1106a)
6 220 100 putative hemolysin activator protein (B. pseudomallei 1710a)
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attenuated  (av) (driver) strains of  B. pseudomallei which 
revealed six strain-specific DNA fragments that were 
unique to the virulent tester strain of B. pseudomallei (v) 
 ( fig. 2 , lane 2), whereas these DNA fragments were not 
seen in the attenuated driver  (av) strain ( fig. 2 , lane 3). The 
fragments in the tester  (v) ranged from 220 to 900 bp in 
length and all the six fragments were subsequently se-
quenced.
 The NCBI BlastX search results for the subtracted 
DNA fragments against  B. pseudomallei  proteins are 
summarized in  table 3 . The results revealed that only four 
of the six sequences had homology to the predicted pro-
teins present in the GenBank database. These were iden-
tified as a xenobiotic-responsive element (XRE) family of 
transcriptional regulator, a plasmid recombination en-
zyme, a regulatory protein and a putative hemolysin ac-
tivator protein with identities of 97, 95, 100 and 100%, 
respectively. The two remaining fragments were a hypo-
thetical protein and an unknown protein with identities 
of 97 and 99%, respectively.
 The results of the two sets of multiplex PCRs are shown 
in  figure 3 . All the six fragments were present in 12 of the 
45 strains and a minimum of three fragments present in 
1 2 3 4 5
600 bp
500 bp
400 bp
300 bp
200 bp
100 bp
440 bp
466 bp
364 bp
293 bp
219 bp
114 bp
Set I
6 7 8 9
Set II
 Fig. 3. Multiplex PCR results (Set I: 466 bp, 364 bp, 293 bp; Set II: 
440 bp, 219 bp, 114 bp) of the 6 representative DNA fragments. 
Lane 1: 100 bp DNA standard; lanes 2 and 6: clinical isolate S4; 
lanes 3 and 7: control virulent strain; lanes 4 and 8: control at-
tenuated strain; lanes 5 and 9: DNA blank. 
1 2 3 4
1,135 kbp
310.1 kbp
33.3 kbp
 Fig. 1. PFGE pulsotypes of virulent  (v) and attenuated  (av) strain 
of  B. pseudomallei. Lanes 1 and 4:  Xba I-digested DNA of S almo-
nella Braenderup (H9812: reference standard), lane 2:  Spe I-digest-
ed DNA of virulent  B. pseudomallei (v) , lane 3:  Spe I-digested DNA 
of  (av) strain of  B. pseudomallei. 
1 2 3 4
1,000 bp
500 bp
100 bp
Fragment 1
Fragment 2
Fragment 3
Fragment 4
Fragment 5
Fragment 6
 Fig. 2. SH of virulent  (v) and attenuated  (av) B. pseudomallei. Lane 
1: 100 bp DNA ladder; lane 2: virulent  B. pseudomallei (v) hybrid-
ized with attenuated  B. pseudomallei (av) ; lane 3:  B. pseudomallei 
(av) hybridized with virulent  B. pseudomallei (v) ; lane 4: control 
(unsubtracted genomic DNA from virulent  B. pseudomallei (v) ). 
 Puthucheary  /Puah  /Chai  /Thong  /Chua  
 
J Mol Microbiol Biotechnol 2012;22:198–204202
9 of the 45 strains indicating that a combination of at least 
three of the virulence determinants identified were pres-
ent in all of the 45 clinical isolates of  B. pseudomallei. The 
distribution of the six fragments in the 45 clinical isolates 
(possible virulence determinants) is shown in  table 4 .
 We have demonstrated by the SH technique, that six 
DNA fragments present in the original virulent strain of 
 B. pseudomallei (v) were significantly absent in the at-
tenuated strain  (av) . The six DNA fragments were recog-
nized as part of genes encoding proteins with homology 
to XRE family of transcriptional regulator, a hypothetical 
protein, an unknown protein, plasmid recombination en-
zyme, regulatory protein and a putative hemolysin acti-
vation protein. A previous SH study between  B. pseudo-
mallei  and a closely related non-infectious environmental 
organism B. thailandensis revealed capsular polysaccha-
ride as a virulence determinant in  B. pseudomallei  [Reck-
seidler et al., 2001] but our study did not demonstrate 
this.
 XRE acts as repressor of defective prophage of  Bacillus 
subtilis 168 (PBSX) and is necessary for the maintenance 
of the bacterial lysogenic state [Wood et al., 1990]. The 
hypothetical protein was predicted to be a member of the 
nitroreductase family protein that is involved in xenobi-
otic biodegradation and metabolism as shown by the 
PATRIC database. Previous studies reported that nitro-
Table 4.   Distribution of ‘virulence determinants’ in 45 clinical isolates of B. pseudomallei
Virulence determinant B . pseudomallei
blood culture
 (n = 24)
non-blood culture
(n = 21)
total
(n = 45)
Transcriptional regulator (F1) 20/24 17/21 37/45
Hypothetical protein (F2) 16/24 14/21 30/45
Unknown protein (F3) 22/24 19/21 41/45
Plasmid recombinant enzyme (F4) 15/24 11/21 26/45
Regulatory protein (F5) 18/24 17/21 35/45
Putative hemolysin activation protein (F6) 21/24 17/21 38/45
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 Fig. 4. Purine biosynthetic pathway in  B. pseudomallei (v) determined by in silico analysis [Jenkins et al., 2011]. 
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reductase proteins can be found in bacterial species such 
as  Helicobacter pylori, Klebsiella  sp. and  Salmonella  ty-
phimurium with their important roles in mediating ni-
trosubstituted compound toxicity and antibiotic resis-
tance [Jenks and Edwards, 2002; Kim and Song, 2005; 
Yanto et al., 2010]. Accordingly, we hypothesize that the 
predicted nitroreductase family protein in  B. pseudomal-
lei may be involved in bacterial adaptation processes.
 B. pseudomallei (v) carried a gene encoding for a plas-
mid recombination enzyme which plays a role in plasmid 
maintenance, and also contributes to the distribution of 
small antibiotic resistance plasmids among bacteria 
[Wood et al., 1990]. Another putative virulent determi-
nant is a regulatory protein and it is predicted to play a 
similar role as a phosphoribosylaminoimidazole carbox-
ylase, catalytic subunit  purE involved in purine metabo-
lism ( fig. 4 ). Interestingly, previous studies have reported 
that a purine metabolism pathway is required for viru-
lence in a variety of pathogens such as  Staphylococcus au-
reus, Vibrio vulnificus and  Bacillus anthracis  [Jenkins et 
al., 2011; Kim et al., 2003; Mei et al., 1997], and Crawford 
et al. [1996] demonstrated that mutant strains defective 
in  purE gene from  Brucella melitensis had reduced viru-
lence in murine models. Hence, further studies of this 
regulatory protein may provide insights into the patho-
genesis of  B. pseudomallei  infections.
 The function of the unknown protein is not predict-
able from the current database but the hemolysin activa-
tion protein might play an important role in the regula-
tion of hemolysin, which appears to represent a virulence 
factor in some human pathogens such as  Mycobacterium 
avium [Maslow et al., 1999] and Listeria monocytogenes 
[Cotter et al., 2008]. Overall, all the six proteins may pos-
sibly play significant roles in the virulence and pathogen-
esis of melioidosis since they were absent in the attenu-
ated strain  (av) which we believe had reduced virulence 
after several subcultures and long-term storage in the lab-
oratory.
 Multiplex PCR carried out on 45 clinical isolates inter-
estingly showed that a combination of at least three of the 
six virulence determinants identified were present in all 
these isolates. Fragment 3 was the most common being 
present in 41 of the 45 (91%) isolates encoding for the un-
known protein according to BlastX results. Fragment 4, a 
plasmid recombinant enzyme, was the least common and 
was present only on 26 of the 45 (58%) isolates. These pos-
sible virulence determinants were fairly equally distrib-
uted between both the blood and non-blood isolates ex-
cept for F4 and F6 which had differences of four frag-
ments between the two types of isolate.
 In conclusion, genomic SH method proved to be use-
ful, whereby we have demonstrated six strain-specific 
DNA fragments of virulent  B. pseudomallei (v)  and ab-
sence of these in the attenuated  (av) strain. Although a 
concrete functional correlation between these six puta-
tive virulence determinants and  B. pseudomallei has yet 
to be confirmed, our preliminary in silico analysis results 
suggest that all appear to be of importance, being present 
in the clinical isolates. Further studies are required to ful-
ly characterize and identify their role(s) in the pathogen-
esis of melioidosis.
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